Vlad Ratziu

23PUBLICATIONS
114CO-AUTHORS
Regenerative medicine (incl. stem cells)Medical biochemistry - lipidsMetabolic medicinePredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Sep 11, 2026
International expert panel review for the use of resmetirom and semaglutide in the management of MASH-related fibrosis: clinical practice update.

|Jul 24, 2026
Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study.

|Dec 31, 2025
Combination therapies for metabolic dysfunction-associated steatohepatitis: challenges and opportunities.

Xiao-Dong Zhou, Qiong-Yue Fan, Christopher D Byrne

|Dec 17, 2025
RIPK1 inhibition reduces biliary injury and fibrosis in primary sclerosing cholangitis.

Pierre-Antoine Soret, Virginie Steunou, Julien Hedou

|Jul 30, 2025
Thrombospondin-2 is a performant biomarker of at-risk MASH and advanced MASH fibrosis in a large multicentre European cohort.

Vlad Ratziu, Rambabu Surabattula, Elisabetta Bugianesi

|Jul 21, 2025
Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis.

Maximilian Jara, Jenny Norlin, Mette Skalshøi Kjær

Pageof 4

Frequent Collaborators

8 joint publications

Jörn M Schattenberg

7 joint publications

Arun J Sanyal

7 joint publications

Quentin M Anstee

4 joint publications

Rohit Loomba